4-[(3-BROMOPHENYL)AMINO]-6-ACRYLAMIDOQUINAZOLINE, 95.0%, 1g

5,6,7,8,9,10-Hexahydrocyclohepta[b]indole, 95.0%, 10g

1-(2-Amino-ethyl)-cyclohexanol, 500mg

3-(2-aminoethyl)-5-(3-chlorophenyl)thiazolidine-2,4-dione hydrochloride, 50mg

3,5-Di(pyridin-2-yl)-4H-1,2,4-triazol-4-amine, 97%, 5g

Ethyl 4,5,6,7-tetrahydro-1H-indazole-3-carboxylate, 95.0%, 1g

Quinoxaline-2-carboxylic acid, 98.0%, 25g

dimethyl yellow indicator solution, 0.2% in ethanol, 100 ml, plastic packaging.

(S)-2-(3-Benzoylphenyl)propanoic acid, 95.0%, 1g

5-(difluoromethyl)-1H-pyrazole-3-carboxylic acid, 95.0%, 1g

6-Methoxy-3(2H)-benzofuranone, 95.0%, 5g

3-Bromo-4'-fluorodiphenyl ether, 97.0%, 5g

Heptanoate (sodium), 100g